Bioconjugate based on cisplatin and bacterial exopolysaccharide with reduced side effects: A novel proposal for cancer treatment-Reference-Cited by-同舟云学术

Bioconjugate based on cisplatin and bacterial exopolysaccharide with reduced side effects: A novel proposal for cancer treatment

Published:2024-05 Issue: Volume:83 Page:127374
ISSN:0946-672X
Container-title:Journal of Trace Elements in Medicine and Biology
language:en
Short-container-title:Journal of Trace Elements in Medicine and Biology

Author:

Queiroz Gian Carlo D.´Angelo de,Dias Fernanda Carolina Ribeiro,Torres Sandra Maria de,Pereira Márcia de Figueiredo,Morais Danielle Barbosa,Silva Wagner Eduardo da,Silva Junior Valdemiro Amaro de

Funder

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Molecular Medicine,Biochemistry

Reference58 articles.

1. On the discovery, biological effects, and use of cisplatin and metallocenes in anticancer chemotherapy;Gómez-Ruiz;Bioinorg. Chem. Appl.,2012

2. Cisplatin in cancer therapy: molecular mechanisms of action;Dasari;Eur. J. Pharm.,2014

3. Renal protective effect of polysulfide in cisplatin-induced nephrotoxicity;Cao;Redox Biol.,2018

4. Advances in toxicological research of the anticancer drug cisplatin;Qi;Chem. Res. Toxicol.,2019

5. Can cisplatin therapy be improved? Pathways that can be targeted;Ali;Int. J. Mol. Sci.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascorbic acid mitigates doxorubicin-induced spleen injury in rats: Histopathological and immunohistochemical insights;PAK J PHARM SCI;2024

2. Ascorbic acid mitigates doxorubicin-induced spleen injury in rats: Histopathological and immunohistochemical insights;PAK J PHARM SCI;2024